Filter Results


Study status

(for at least one location)



Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-9 of 9 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of RO7303509 in Participants With Systemic Sclerosis

    Rochester, MN

  2. PRA023 in Subjects with Systemic Sclerosis Associated with Interstitial Lung Disease

    Scottsdale/Phoenix, AZ

  3. A Trial to Evaluate the Effectiveness, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis

    Rochester, MN

  4. UVA1 Phototherapy in Patients with Scleroderma-Related Raynaud’s Phenomenon

    Jacksonville, FL

  5. A Study to Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

    Scottsdale/Phoenix, AZ

  6. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis

    Rochester, MN

  7. A Registry to Track Scleroderma Progression

    Rochester, MN

  8. Assessment of Sleep Disorder Breathing Risk in Patients with Scleroderma

    Scottsdale/Phoenix, AZ

  9. Scleroderma Registry

    Rochester, MN


Mayo Clinic Footer